Q2 2016 Holdings
Filed 2016-08-15 | 147 holdings | $3.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $247 | 12,949 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $250 | 20,269 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $250 | 30,885 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $250 | 6,443 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $252 | 17,302 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $253 | 17,649 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $256 | 63,191 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $257 | 6,986 | 0.0% |
| Synergy Pharmaceuticals del | COM NEW | 871639308 | $259 | 68,254 | 0.0% |
| Celldex Therapeutics Inc New | COM | 15117B103 | $261 | 59,537 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $262 | 25,630 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $263 | 9,762 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $263 | 20,302 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $264 | 13,046 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $264 | 8,774 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $264 | 24,463 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $265 | 32,726 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $267 | 75,100 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $267 | 6,165 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $270 | 5,281 | 0.0% |
| Novavax Inc | COM | 670002104 | $273 | 37,550 | 0.0% |
| Newlink Genetics Corp | COM | 651511107 | $275 | 24,463 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $285 | 12,651 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $335 | 17,649 | 0.0% |
| Cheniere Energy Partners LP(CQP) | COM UNIT | 16411Q101 | $350 | 11,685 | 0.0% |
| Merrimack Pharmaceuticals in | COM | 590328100 | $472 | 87,477 | 0.0% |
| Arena Pharmaceuticals Inc | COM | 040047102 | $475 | 277,607 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $484 | 4,147 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $489 | 66,113 | 0.0% |
| Progenics Pharmaceuticals in | COM | 743187106 | $499 | 118,285 | 0.0% |
| Medicines Co | COM | 584688105 | $502 | 14,919 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $512 | 5,955 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $514 | 36,153 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $514 | 23,292 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $514 | 48,887 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $519 | 1,485 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $520 | 48,151 | 0.0% |
| Relypsa Inc | COM | 759531106 | $521 | 28,163 | 0.0% |
| Enlink Midstream LLC(0E41) | COM UNIT REP LTD | 29336T100 | $528 | 33,190 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $529 | 61,274 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $531 | 5,386 | 0.0% |
| Raptor Pharmaceutical Corp | COM | 75382F106 | $535 | 99,654 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $537 | 5,073 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $539 | 21,130 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $541 | 3,557 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $543 | 6,511 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $545 | 6,820 | 0.0% |
| PDL Biopharma Inc(PDLI) | COM | 69329Y104 | $546 | 173,837 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $546 | 3,826 | 0.0% |
| Medivation Inc | COM | 58501N101 | $546 | 9,058 | 0.0% |